NCT05778383View on ClinicalTrials.gov

Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

February 23, 2022

Study Completion Date

May 25, 2022

Conditions
Zinc DeficiencySars-CoV-2 Infection
Interventions
DIETARY_SUPPLEMENT

Zinc Acetate

Each participant allocated in the intervention arm will be treated as Standard of Care and will be supplemented with 240mg of Zinc Acetate

Trial Locations (1)

08003

Hospital del Mar, Barcelona

All Listed Sponsors
collaborator

Universitat Pompeu Fabra

OTHER

lead

Parc de Salut Mar

OTHER